Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1993
12/28/1993US5273989 3,5-disubstituted 2-isoxazolines and isoxazoles, agents containing them and their use
12/28/1993US5273986 Cycloalkylthiazoles
12/28/1993US5273984 Salts formed between basic histamine H2 -receptor antagonists and bismuth complexes
12/28/1993US5273983 2-Piperidinylmethylcyclohexylaminocarbonyl-substituted benzene
12/28/1993US5273979 Rapamycins; preventing transplant rejection
12/28/1993US5273977 Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents
12/28/1993US5273976 Ocular hypotensive agents
12/28/1993US5273974 Condensed heterocyclic compounds, their production and use
12/28/1993US5273972 [(2-diakylaminomethyl)-3-quinuclidinyl]-benzamides and benzoates
12/28/1993US5273971 13-alkyl-11β-phenylgonanes
12/28/1993US5273970 Treatment of protozoal diseases
12/28/1993US5273965 A reduced and hydrolyzed saponin from a Quillaja saponaria extract
12/28/1993US5273892 Culturing Pseudomonas
12/28/1993US5273760 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
12/28/1993US5273759 Method and composition for treating the migraine complex
12/28/1993US5273754 A mixture of a heating carminative, vanillylamide, and a cooling carminative, e.g. mint
12/28/1993US5273753 A glucosyl- or fructosyltransferase in a solution containing sodium alginate to produce a water-soluble polysaccharide from sucrose
12/28/1993US5273747 Commiphora mukul extracts and therapeutical applications thereof
12/28/1993US5273742 Replacing ocular fluid in a mammal eye using an aqueous solution of hydrogel polyoxyethylene glycol polyurethane; nontoxic
12/28/1993US5273740 Modified by a quaternary ammonium group; cationic polymers also containing a divinylbenzene monomer
12/28/1993CA1325638C Process for preparing azetidinones
12/28/1993CA1325634C Esters of hexahydro-8-hydroxy-2,6-methano-2h- quinolizin-3(4h)-one and related compounds
12/28/1993CA1325633C Derivatives of glutamic acid and aspartic acid having antagonistic activities towards bioactive polypeptides and method for their preparation
12/28/1993CA1325632C .beta.-carbonyl-carboxyamides of 1,3-thiazolidines
12/28/1993CA1325631C Phenothiazine derivatives with analgesic properties
12/28/1993CA1325630C Lysocellin solids purification process
12/28/1993CA1325599C Cosmetic composition
12/28/1993CA1325597C Expectorant comprising hydroxyalkylcysteine derivative
12/28/1993CA1325596C Non-aqueous topical composition containing an ester of pyroglutamic acid
12/28/1993CA1325595C Lubricant composition containing phospholipid and hyaluronic acid
12/28/1993CA1325594C Agents for the prophylaxis and therapy of retroviral infections
12/28/1993CA1325593C Composition of matter for increasing intracellular atp levels and physical performance levels and for increasing the rate of wound repair
12/27/1993CA2099078A1 Imidazolyl-substituted cyclohexane derivatives
12/27/1993CA2099068A1 Imidazolyl-substituted phenylpropionic and cinnamic acid derivatives
12/26/1993CA2099648A1 Aminoalkylcarbamic esters of eseroline suitable for use as cholinesterase activity inhibitors and relative preparation process
12/26/1993CA2098650A1 Substituted 1,2,4-triazine-3,5-dione derivative and anticoccidial drug composition containing the same as active component
12/26/1993CA2098166A1 Hydroxamic acid derivatives
12/25/1993CA2099062A1 Branched alkylamino derivatives of thiazole, processes for preparing them and pharmaceutical compositions containing them
12/25/1993CA2098222A1 Triazole derivatives
12/24/1993CA2098982A1 Indolizine derivatives, process of preparation and use for the preparation of aminoalkoxybenzenesulphonylindolizine compounds with pharmaceutical activity
12/23/1993WO1993026053A1 Micromechanical thermoelectric sensor element
12/23/1993WO1993025694A1 Inhibitors of ced-3 and related proteins
12/23/1993WO1993025682A2 Chimeric receptor polypeptides, human h13 proteins and uses thereof
12/23/1993WO1993025679A1 Novel polypeptides having nmda receptor activity, nucleic acids encoding said polypeptides and applications
12/23/1993WO1993025673A1 In vivo gene therapy with intron-free sequence of interest
12/23/1993WO1993025583A2 Proteinoid carriers and methods for preparation and use thereof
12/23/1993WO1993025574A1 Inhibitors of angiotensin i chymase(s) including human heart chymase
12/23/1993WO1993025570A1 Novel steroids with pregnane skeleton, pharmaceutical compositions containing them and process for preparing same
12/23/1993WO1993025568A2 Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use
12/23/1993WO1993025565A1 1,5-anhydrohexitol nucleoside analogues and pharmaceutical use thereof
12/23/1993WO1993025558A1 2-aminoethanesulfonic acid/zinc complex compound
12/23/1993WO1993025557A1 Process for the preparation of clavulanic acid
12/23/1993WO1993025555A1 Derivatives of imidazo [5,1-c][1, 4]benzoxazin-1-one as 5 ht3 antagonists
12/23/1993WO1993025554A1 Benzodiazepines and compositions for treating anxiety and panic disorders, and idiopathic and psychomotor epilepsy
12/23/1993WO1993025553A1 Pyridino-, pyrrolidino- and azepino-substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agents
12/23/1993WO1993025552A1 Process and intermediates for bis-aza-bicyclic anxiolytic agents
12/23/1993WO1993025551A1 3-substituted carbacephems
12/23/1993WO1993025550A1 Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same
12/23/1993WO1993025548A1 5-(1,2,4-triazol-1-ylmethyl)-3h-isobenzofuran-1-one derivatives, their preparation and use as aromatase inhibitors
12/23/1993WO1993025547A1 The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy
12/23/1993WO1993025545A1 Novel quinoline derivatives and processes for preparing the same
12/23/1993WO1993025543A2 Enniatines and enniatine derivates used to control endoparasites
12/23/1993WO1993025539A1 Novel piperzinyl-bis(alkylamino)pyrimidine derivatives and process for preparing same
12/23/1993WO1993025536A1 1,2,3-triazole and imidazole compounds and their antitumor use
12/23/1993WO1993025534A1 2,5-DIOXO-2,5-DIHYDRO-1H-BENZ[b]AZEPINES AS NMDA RECEPTOR ANTAGONISTS
12/23/1993WO1993025530A2 Vinyl arenas having retinoid-like activity
12/23/1993WO1993025527A1 Dimeric piperidine, tetrahydropyridine and piperazine derivatives
12/23/1993WO1993025521A1 Aryl aliphatic acids
12/23/1993WO1993025517A1 Trisubstituted phenyl derivatives as selective phosphodiesterase iv inhibitors
12/23/1993WO1993025238A1 Stable imidazole anti-fungal powder compositions
12/23/1993WO1993025225A1 Liposomal formulations for administering to cancer patients
12/23/1993WO1993025224A1 Pharmaceutical preparations for inhibiting tumours associated with prostate adenocarcinoma, stomach cancer and breast cancer
12/23/1993WO1993025223A1 Rxr homodimer formation
12/23/1993WO1993025219A1 Prevention and treatment of peripheral neuropathy
12/23/1993WO1993025214A1 Veterinary rehydration product
12/23/1993WO1993025209A1 Compositions for the treatment and prophylaxis of inflammations and dermatoses induced by viruses and process for the preparation thereof
12/23/1993WO1993025208A1 Spermicidal and cytocidal fatty acid compositions
12/23/1993WO1993025207A1 Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine isethionate for the treatment and prevention of dependence, tolerance and sensitization of drugs
12/23/1993WO1993025206A1 ORALLY ADMINISTRABLE COMPOSITION OF PYRIDO[1,2-a]PYRIMIDINE DERIVATIVE
12/23/1993WO1993025205A1 Pyrazolopyridine compounds for the treatment of anemia
12/23/1993WO1993025204A1 Gastro-protected stable omeprazole compositions in the form of microgranules and process for their production
12/23/1993WO1993025203A1 Method of treating and protecting against central nervous system ischemia, hypoxia, degeneration, and trauma with a 5-aminocarbonyl-sh-dibenzo[a,d]cyclohepten-5,10-imine
12/23/1993WO1993025201A1 Compositions and methods for treating autoimmune diseases
12/23/1993WO1993025200A1 Use of fatty acids, e.g. z-hydroxymystic acids, as antiviral agents
12/23/1993WO1993025199A1 Alpha-2-adrenergic agonists for treating presbyopia
12/23/1993WO1993025196A1 Methods for treating non-suturable wounds by use of cyanoacrylate adhesives
12/23/1993WO1993025188A1 Lenitive composition and method
12/23/1993WO1993025179A1 Emulsifier salt compositions for applying silicone oil to hair
12/23/1993WO1993022434A3 Targeted cleavage of rna using eukaryotic ribonuclease p and external guide sequence
12/23/1993DE4300463A1 Prepn. of carbamic acid in aq. soln. useful as plant nutrient or for healing wounds - by reacting gaseous carbon di:oxide and nitrogen@ with mixed liq. phase catalyst then hydrolysing prod. in water bath
12/23/1993DE4243287A1 N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung N-substituted Azabicycloheptan derivatives, their preparation and use
12/23/1993DE4220379A1 Medical use of fused-ring di:hydro-pyridine derivs. - for preparing medicaments against ulcerative colitis and Crohn's disease
12/23/1993DE4220324A1 Treating chronic inflammatory conditions, e.g. bronchial asthma - using bis:(3,4-di:hydro-1-pyridyl)-methane deriv. which block non-selective cation channels
12/23/1993DE4220320A1 Use of fused-ring di:hydro-pyridinyl methane derivs. - as anti-proliferative agents, esp. deriv. with spiro-isoquinolinyl structure
12/23/1993DE4219973A1 N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung N-substituted Azabicycloheptan derivatives, their preparation and use
12/23/1993DE4219843A1 Compsns. contg. tamoxifen or related cpds. - for treating leukaemia and retroviral-induced immune deficiency
12/23/1993DE4219782A1 New benzimidazol-1-yl-methyl-bi:phenyl derivs.
12/23/1993DE4219659A1 Bronchial asthma treatment with PAF-antagonist - esp. thieno:triazolo:diazepine deriv., in presence of anticholinergic agent for synergistic effect
12/23/1993CA2418594A1 Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use
12/23/1993CA2138415A1 1,5-anhydrohexitol nucleoside analogues and pharmaceutical use thereof
1 ... 7143 7144 7145 7146 7147 7148 7149 7150 7151 7152 7153 7154 7155 7156 7157 7158 7159 7160 7161 7162 7163 ... 7860